NASDAQ:ACXP | Income Statement | Acurx Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$1.07M$2.31M-$2.31M-$2.25M-$0.53-$0.534,259,5404,259,540
2026-03-31$341,468.00$1.72M-$1.72M-$1.68M-$0.62-$0.622,718,4332,718,433
2025-12-31$281,807.00$1.62M-$1.62M-$1.58M-$0.31-$0.31223,201223,201
2025-09-30$429,691.00$2.03M-$2.03M-$1.99M-$1.23-$1.231,625,8051,625,805
2025-06-30$524,210.00$2.27M-$2.27M-$2.25M-$1.89-$1.891,190,2661,190,266
2025-03-31$598,798.00$2.18M-$2.18M-$2.15M-$2.15-$2.151,001,9321,001,932
2024-12-31$825,059.00$2.79M-$2.79M-$2.78M-$3.22-$3.2212,77912,779
2024-09-30$1.2M$2.83M-$2.83M-$2.82M-$3.45-$3.45818,174818,174
2024-06-30$1.83M$4.12M-$4.12M-$4.12M-$5.21-$5.21791,233791,233
2024-03-31$1.56M$4.38M-$4.38M-$0.28-$0.2815,472,50715,472,507
2023-12-31$1.94M$5.11M-$5.11M-$0.38-$0.38389,568389,568
2023-09-30$1.35M$3.11M-$3.11M-$0.24-$0.2413,005,12813,005,128
2023-06-30$1.74M$3.45M-$3.45M-$0.28-$0.2812,186,48112,186,481
2023-03-31$1.02M$2.9M-$2.9M-$0.25-$0.2511,639,39511,639,395
2022-12-31$1.43M$3.26M$0.00-$3.26M-$0.28-$0.28264,909264,909
2022-09-30$1.59M$3.54M-$3.54M-$0.32-$0.3211,148,40211,148,402
2022-06-30$911,692.00$0.00$2.62M-$2.62M-$0.26-$0.2610,263,20210,263,202
2022-03-31$818,888.00$113,100.00$2.67M$0.00-$2.67M-$0.26-$0.2610,232,84310,232,843
2021-12-31$716,223.00$0.00$2.63M-$2.63M-$0.22-$0.22547,310547,310
2021-09-30$1.13M$4.64M-$4.64M-$0.46-$0.4610,116,40310,116,403
2021-06-30$95,074.00$4.07M-$4M-$0.57-$0.576,968,3416,968,341
2021-03-31$91,908.00$1.47M-$1.47M-$0.21-$0.216,867,2896,867,289
2020-12-31$457,533.00$1.09M-$1.09M-$0.16-$0.16153,621153,621
2020-09-30$659,977.00$1.31M-$1.31M-$0.21-$0.216,266,5846,266,584
2020-06-30$400,738.00$913,360.00-$913,360.005,975,971
2020-03-31-$1.28M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.83M$8.09M-$8.09M-$7.97M-$5.32-$5.321,498,7931,498,793
2024-12-31$5.4M$14.12M-$14.12M-$14.1M-$17.45-$17.45808,168808,168
2023-12-31$6.04M$14.58M-$14.58M-$1.15-$1.1512,671,57212,671,572
2022-12-31$4.75M$12.09M$0.00-$12.09M-$1.12-$1.1210,816,41210,816,412
2021-12-31$2.03M$208,270.00$12.81M-$12.75M-$1.49-$1.498,535,8738,535,873
2020-12-31$2.2M$4.6M$0.00-$4.6M-$0.74-$0.746,190,8756,190,875